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Abstract: TNF is a pleiotropic cytokine and shows its biological function by binding to its receptors called TNFR1 and TNFR2. While
TNFR1 induces apoptosis by activation of caspase-8 via the “death domain”, it also activates IKKα/β, MKK3/6, MKK4/7 by activation of
TAK1. Although the TNFR1 signaling pathway is known by in large, it is not known how AKT and MAPKs p38, ERK1/2, and JNK1/2
are activated. The presence of a proline-rich PPAP region, (P448PAP451, a binding site for the SH3 domain-containing proteins) very close
to the C-terminus promoted us to determine whether this region has any role in the TNFR1 signal transduction. To test this, the codons
of P448 and P451 were changed to that of Alanin, GCG, via site-directed mutagenesis, and this plasmid was named as TNFR1-SH3-P/A.
Subsequently, ectopically expressed the wild type TNFR1 and TNFR1-SH3-P/A in 293T cells and determined the levels of TNF-α-mediated phosphorylations of ERK, p38, JNK and AKT, NF-kB, and caspase-8 activation. While ectopic expression of our mutant diminished
TNFα-mediated phosphorylations of p38, JNK, ERK and AKT, it increased NF-kB, and caspase-8 activations. In conclusion, TNFα-mediated ERK, AKT, JNK, p38 activations are affected by TNFR1 SH3 domain modifications.
Key words: TNF-α, TNFR1, Grb2, ERK, AKT

1. Introduction
Tumor necrosis factor-alpha (TNFα) is a multifunctional
cytokine. It has a detrimental role in the activation of the
immune system, inflammation, differentiation and tumor
toxicity (Sedger et al., 2014; Kalliolias and Ivashkiv, 2016).
Two different types of signaling cascades are initiated after
binding of TNFα to its receptors, TNFR1 and TNFR2
(Grel et al., 1994). TNFα binds to homotrimers of TNFR1.
This facilitates binding of TRADD (tumor necrosis factor
receptor type 1-associated death domain) to TNFR1 which
then initiates the assembly of complex-1. The formation of
complex-1 is known to be responsible for TNF-mediated
activation of p38, JNKs and NF-kB. Therefore, activation
of this promotes apoptosis (Micheau and Tschopp, 2003),
necroptosis (He et al., 2009) and the activation of NF-kB
(Boone E et al., 1998; Ozes et al., 1999; Fan et al., 2010).
Upon the binding of TNFα, TNFR1 is activated and binds
to DD (death domain) (Tartaglia et al., 1993) bearing
proteins such as TRADD (TNF receptor-associated death
domain) and RIP1 (receptor-interacting serine-threonine
kinase 1) (Hsu et al., 1995; Hsu et al., 1996a, 1996b) via
its DD located between the amino acids 356-441. The
binding of TRADD and RIP1 to TNFR1 initiates the
formation of complex-1, composed of the Fas-associated
death domain (FADD) and procaspase-8, TRAF2 (TNF-

receptor associated factor-2), LUBAC (linear ubiquitin
chain assembly complex), cIAP1/2 (cellular inhibitor of
apoptosis protein 1/2), and TAK1 (transforming growth
factor-activated kinase-1) (Rothe et al., 1995; Shu et al.,
1996; Park et al., 2004; Ea et al., 2006; Zheng et al., 2006;
Jackson-Bernitsas et al., 2007; Bertrand et al., 2008;
Varfolomeev et al., 2008; Haas et al., 2009; Tokunaga et
al., 2009; Gerlach et al., 2011). In this complex, TAK1 is
activated first, then it directly phosphorylates the mitogenactivated protein kinase kinases, MKK3/6, MKK4/7
(mitogen-activated protein kinase kinases) as well as
IKK (inhibitor of nuclear factor-kB kinase) complex. The
phosphorylations of these enzymes result in the activation
of p38, JNKs (c-Jun N-terminal kinases), and NF-kB
(nuclear factor-kappa B) pathway (Wang et al., 2001).
Even though the formation of complex-1 appears
to explain how TNFα induces the activation of p38,
JNKs, and NF-kB, it does not explain TNFα-mediated
phosphorylations (activations) of the ERK (extracellular
signal-regulated kinase), AKT (protein kinase B), and
Stat3 (signal transducer and activator of transcription 3).
With this in mind, and knowing that phosphorylations
of ERK1/2 and AKT require the activation of Grb2-RasRAF pathway (Zou J et al., 2019; Steelman et al., 2011), we
postulated that the presence of SH3-domain (Src homol-
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ogy 3 domain) binding motif P448PAP451 at the C-terminal
of TNFR1 could be a binding site for adaptor protein Grb2
(growth factor receptor-bound protein 2), which contains
the SH3 domain. To test our hypothesis, we converted
the codons of P448 and P451 to that of Alanine using
site-directed mutagenesis on the TNFR1 expression vector. Transient transfection of this mutant vector into 293T
cells resulted in ectopic expression of mutant TNFR1 protein. Then, we tested the impact of this mutant receptor on
TNFα-mediated phosphorylation of p38, ERK1/2, AKT,
and activations of NF-kB and caspase-8. In this study we
show for the first time that the disruption of SH3 domain-binding motif of TNFR1 resulted in a diminishment of
TNFα-induced phosphorylations of p38, ERK, AKT, and
increased activation of NF-kB.
2. Materials and methods
2.1. Antibodies and reagents
Recombinant human TNFα was purchased from SigmaAldrich (St. Louis, MO, USA) (H8916), antibodies for
TNFR1 (sc-8436), pERK (sc-7383), ERK (sc-94), pJNK
(12882), JNK (7345), and GAPDH (sc-47724) were from
Santa Cruz Biotechnology (Dallas, TX, USA). Monoclonal
primary antibodies for pAkt (9271S), Akt (9272S) pp38
(9211L), and p38 (9212S) were from Cell Signaling
Technology (Danvers, MA, USA) (NEB) and HRP
conjugated secondary antibodies to mouse and rabbit IgG
was from KPL (Gaithersburg, MD, USA) (474-1806 and
474-1506).
2.2. Plasmids and mutagenesis
TNFR1 expression plasmid was obtained by cloning
TNFR1 ORF into pcDNA3.1A backbone. Following
validation of vector efficiency by transfection into
HEK293T cells, we proceeded with site direct
mutagenesis. Site-directed mutagenesis was performed
by Pfu polymerase (Agilent/Stratagene, La Jolla, CA,
USA) reaction followed by Dpn1 digestion and plasmid
sequences were verified by Sanger sequencing using
Applied Biosystems 3130XL (Thermo Fisher Scientific,
Waltham, MA, USA). The mutagenesis primers were:
Forward: ‘5-cccgccgccctcgcgcccgcggccagtcttctcagatg-3’
Reverse: ‘5-catctgagaagactggccgcgggcgcgagggcggcggg-3’
2.3. Cell culture, transfections and treatments
HEK293T cells with passage numbers smaller than
22, were maintained grown in high glucose DMEM
medium with stable L-glutamine (Lonza, Verviers,
Belgium), supplemented with 10% fetal bovine serum
(Gibco, Thermo Fisher Scientific) and 1% penicillin/
streptomycin/amphotericin B (Biological Industries, BeitHaemek, Israel), under standard 80%–90% humidity,
5% CO2 cell culture environment. CaPO4 precipitation
method was utilized for transfections. TNFα stimulations
were performed following 16 h serum starvation and
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1-h pretreatment with 100 µM sodium orthovanadate
(Na3VO4).
2.4. Western blot
The cell lysate protein concentrations acquired in the
lysis buffer [1.2% Triton X-100, 150 mM NaCl, 20 mM
Tris-HCl (pH 7.4), 1 mM EGTA, 1 mM EDTA, 1 mM
PMSF, 10 g/mL leupeptin, 0.15 U/mL aprotinin, 10 g/
mL pepstatin A, and 1 mM Na3VO4] were calculated
utilizing the Bradford method. One hundred micrograms
of protein lysates were fractionated by SDS-PAGE on
10% polyacrylamide gels and transferred overnight to
Immobilion-P PVDF membranes. Blots were probed with
primary antibodies and corresponding HRP-conjugated
secondary antibodies, and proteins were detected using
Clarity ECL Western blotting substrate (1705061, Bio-Rad
Laboratories, Hercules, CA, USA).
2.5. Caspase-8 activation assay
Caspase-8 activities were measured according to the
producer’s guidelines with a colorimetric caspase assay kit
(K113-200, BioVision Inc. Milpitas, CA, USA). Concisely,
293T cells were treated or untreated for 24 h with 10 ng/
mL TNF alpha at the 48th hour of transfection. Cells were
lysed with cellular lysis buffer and protein concentration
was determined. One hundred fifty micrograms lysate
volume with cell lysis buffer was added to 50 μL and 50 μL
2X reaction buffer with 10 mM DTT was added. Lysates
were incubated for 2 h with DEVD-pNA pNA (200 µM)
and colorimetric measurements were made at a wavelength
of 405 nm (nanometer).
2.6. NF-kB activation assay
The effect of mutant and wild type TNFR1 on NF-kB
activity induced by TNFα was tested with the NF-Luc
assay method. Concisely, 293T cells were cotransfected
with plasmid reporter 150 ng/well (nanogram/well) NFkB luciferase and 150 ng/well TNFR1 expression vectors by
reverse transfection of Lipofectamine 2000. At transfection
time of 48th hour, cells were incubated for 6 h with 10 ng/
mL TNFα. Luciferase activity was assessed utilizing ONEGlo luciferase assay system (E6120, Promega, Madison,
WI, USA) as directed by the manufacturer. Briefly
clarified, medium from the wells were changed and, 50
μL fresh medium was added. Fifty microliters ONE-Glo
reagent was then applied to the wells and enabled for 3
min of lysis. Samples were moved quickly to luminometer
plates and luminometric observations were performed.
We normalized luciferase observations with MTT analysis
to exclude cell number-caused variations.
2.7. Statistical analysis
The sensitivity of the Western blot image was calculated
by ImageJ program. Graphs have been determined using
Prism 6 (GraphPad Software) and data are presented as
mean values ± SEM. All data were statistically analyzed by
the Mann–Whitney U test.
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3. Results
3.1. Overexpression of wild type TNFR1 and TNFR1SH3-P/A in 293T cells
As mentioned above, we have created SH3-binding
domain mutant of TNFR1 by changing the codons of P448
and P451 to that of Alanine (Figure 1A) and confirmed
the changes by Sanger sequencing (Figure 1B). Then, we
demonstrated whether mutant TNFR1-SH3-PA protein
can be expressed in 293T cells. To determine the ectopic
expression of wild type and mutant TNFR1, 30 μg of
plasmids were transfected into 293T cells using Caphosphate for 16 h, followed by medium replacement.
Cell lysates were collected after 72 h of transfection and

total cellular lysates were prepared in lysis buffer. One
hundred micrograms of lysates were fractionated on 10%
SDS-PAGE. As shown in Figure 1C, 293T cells express
a very low level of endogenous TNFR1. However, after
transfection, we achieved 600-fold wild type TNFR1 and
1000-fold TNFR1-SH3-P/A ectopic expression when
normalized to background TNFR1 expression.
3.2. The effect of TNFR1-SH3-P/A on TNFα-mediated
ERK and AKT phosphorylations
We thought that TNFα-mediated phosphorylations
of ERK1/2 and AKT simply cannot be explained by
the formation of complex-1 during “canonical TNFα
signaling”. To shed light on this issue, we considered that

Figure 1. A proline-rich PPAP region, “P448PAP451”, a binding site for proteins containing the SH3 domain very close to the Cterminus, was discovered in the translation map of the TNFR1. The SH3 domain recognition sequence PPAP of TNFR1 is underlined
in red. (A) The mutant TNFR1 was generated using site-directed mutagenesis. The Sanger sequence analysis was performed via Sanger
sequencing, and the sequences of antisense strand of wild type and reverse strand of mutant TNFR1 were confirmed. (B) The wild type
and mutant TNFR1 (TNFR1-SH3-P/A) can be ectopically expressed in 293T cells. (C) To determine ectopic expression of wild type and
mutant TNFR1, both vectors were transfected into 293T cells (30 µg/10 cm plate) via calcium phosphate protocol for 48 h 100 µg of total
cell lysates were used for western blotting. Fold changes of wild type and mutant proteins were determined by normalizing GAPDHcorrected values to that of background TNFR1.
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SH3-binding sequence PPAP at the far C-terminal of the
TNFR1 could play a role in TNFα-induced activations
of ERK1/2 and AKT, whose activations require Grb2Ras-Raf pathway. To test this, we transiently transfected
293T cells with wild type and mutant plasmid for 2 days,
serum-starved them for 16 h, then treated with TNFα (10
ng/mL). Since we previously showed the maximum time
points of TNFα-induced phosphorylations of ERK1/2 and
AKT (Hapil et al., 2020), we treated cells for 15 and 30
min to detect pERK1/2 and 2–30 min to detect pAKT. As
shown in Figure 2A, TNFα induced 4.2-fold induction of
ERK1/2 phosphorylation at 15 min and 3.8-fold induction
of AKT phosphorylation at 30 min (Figure 2B) post-TNFα
stimulation in wild type TNFR1 expressing cells. However,
the induction of phosphorylation of ERK1/2 was only
1.7-fold in TNFR1-SH3-P/A expressing cells at 15th min
post-TNFα stimulation (Figure 2A). More importantly,
in TNFR1-SH3-P/A expressing cells TNFα-induced
phosphorylation of AKT was completely ablated, in fact,
background level of AKT phosphorylation gradually
declined with time and at 30th min we detected only 1/5
of background level of AKT phosphorylation (Figure 2B).
These results clearly indicate that SH3-binding domain of
TNFR1 plays a significant role in transmission of signals
which culminate in phosphorylations of ERK1/2 and AKT
after TNFα stimulation.
3.3. The effect of TNFR1-SH3-P/A on TNFα-mediated
p38 and JNK1/2 phosphorylations
According to “canonical TNFα signaling” formation of
complex-1 and activation of TAK1 kinase in this complex

is a must to phosphorylate and activate MKK3/6 and
MKK4/7, which phosphorylate and activate p38 and
JNK1/2, respectively. From this point of view, there seems
to be no involvement of SH3-binding domain in activation
of TAK1. However, after showing the effect of TNFR1SH3-P/A mutant on phosphorylation of ERK1/2 MAPK,
we wanted to test whether our mutant would affect TNFαinduced phosphorylations of the other MAPKs p38 and
JNK1/2. Similar to ERK1/2 phosphorylation, we previously
showed (Hapil et al., 2020) the 15th min as the maximum
time point for TNFα-induced phosphorylations of p38 and
JNK1/2. Therefore, in this experiment, we determined the
level of phosphorylations of p38 and JNK1/2 at 15 and 30
min post-TNFα stimulation. As shown in Figure 3A, TNFα
induced 6.3-fold induction of p38 phosphorylation at 15
min and this dropped to 4.2-fold at 30th min. In wild typeTNFR1 expressing cells, however, in 293T cells expressing
mutant TNFR1 maximum level of phosphorylation was
4-fold at 15th min and this dropped to 2-fold at 30th min
post-TNFα stimulation. When we look at the levels of
phospho-JNK1 and 2 in the same lysates, we found 2.7and 2.3-fold induction of phosphorylations of JNK1 and 2
at 15th min. post-TNFα stimulation in wild type TNFR1
expressing cells, respectively, Figures 3B and 3C. More
importantly, phosphorylations of JNK1 and 2 in mutant
TNFR1 expressing cells were only 1.2- and 1-fold at 30th
min post-TNFα stimulation (Figures 3B and 3C). These
results clearly indicate that PPAP sequence is somehow
involved in the formation of complex-1 and activation of
TAK1 after TNFα stimulation.

Figure 2. The mutant TNFR1 (TNFR1-SH3-P/A) interferes with TNFα-mediated phosphorylations of ERK1/2 and AKT kinases. Pattern of TNF-α-induced phosphorylations ERK1/2 (A) and AKT (B) were explored by western blot of 100 µg lysates obtained from 293T
cells treated with TNF-α for the indicated time points. To determine the fold changes in phosphorylations, the band intensities of the
images were determined using ImageJ, and the numerical values of phospho bands were divided into that of nonphospho bands.
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3.4. The effect of TNFR1-SH3-P/A on NF-kB and caspase-8 activation
The TNFα signaling resulting in activations of kinases
ERKs, JNKs, p38s, AKTs, and NF-kB is very transient and
is terminated by deubiquitinases A20 and CYLD (ubiquitin
carboxyl-terminal hydrolase), which deubiquitinate
TRADD, RIP1, NEMO (NF-kappa B essential modulator),
and TRAF2. After the deubiquitination, the complex-1
disassembles and released TRADD/RIP1 translocates
to the cytoplasm and participates in the formation of
complex-2a which induces activation of caspase-8 and
induction of apoptosis (Opipari et al., 1990; Trompouki
et al., 2003; Malynn and Ma, 2009; Verhelst et al., 2014;
Legarda et al., 2016).
Even though the PPAP sequence has not been related
to induction of NF-kB or activation of caspase-8 in the
past, and we showed that transient expression of our
mutant TNFR1 unexpectedly affected TNFα-induced
phosphorylations of p38 and JNK1/2, (activation of which
does not require Grb2-Ras pathway), we thought that
our mutants might also affect TNFα-induced activations
of NF-kB and caspase-8. To test this, PC-3 (mock), wildtype TNFR1, and mutant TNFR1 vectors were transfected
into 293T cells for 48 h, then cells were treated with 10
ng/mL TNFα for 24 h. Cellular lysates were collected
and caspase-8 activation was measured immediately by
colorimetric caspase-8 activation assay. As shown in Figure
4A, transient expression of wild type and mutant TNFR1
significantly increased background level of caspase-8
activity and mutant TNFR1 did not show any negative
effect against TNFα-induced caspase-8 activation. To
determine the effect of our mutant on TNFα-induced

NF-kB induction, 293T cells were cotransfected with 150
ng/well NF-kB luciferase reporter plasmid and 150 ng/
well TNFR1 expression vectors by Lipofectamine 2000
reverse transfection in 96-well plates. At the 48th hour of
transfection, cells were treated with 10 ng/mL TNF-α for 6
h. At the end of treatment, luciferase activity was measured
using ONE-Glo luciferase assay system (Promega, E6120)
according to the manufacturer’s instructions. As shown in
Figure 4B, expressions of TNFR1 increased background
level of luciferase activity and this was further induced
with TNFα stimulation. Unexpectedly, however, TNFR1SH3-P/A mutant not only boosted background level of
luciferase expression more than TNFR1, it also augmented
TNFα-induced luciferase expression 3 times more than
wild type TNFR1.
4. Discussion
TNFR1 is the death domain bearing receptor for the
pleiotropic cytokine TNFα. In the past 30 years, initiation
and transduction of TNFα signaling have been extensively
studied and the proteins involved in these signaling
pathways have been identified. Overall, TNFα signaling
initiated from TNFR1 is very complex and organized
via orderly bindings of TRADD-RIP1-TRAF2-cIAP1/2
and LUBAC to TNFR1. After the formation of this
complex on TNFR1, TRADD-RIP1-NEMO and TRAF2
are ubiquitinated and these ubiquitinations serve as
docking sites for TAB2/3-TAK1 and NEMO-IKKα-IKKβ
complexes, resulting in the formation of complex-1 (Rothe
et al., 1995; Hsu et al., 1995; Hsu et al., 1996; Hsu et al., 1996;
Shu et al., 1996; Park et al., 2004; Ea et al., 2006; Zheng et
al., 2006; Jackson-Bernitsas et al., 2007; Varfolomeev et

Figure 3. The mutant TNFR1 (TNFR1-SH3-P/A) interferes with TNFα-mediated phosphorylations of p38 and JNK kinases. Pattern
of TNF-α-induced phosphorylations p38 (A) and JNK1 (B) and JNK2 (C) were explored by Western blot of 100 µg lysates obtained
from 293T cells treated with TNF-α for the indicated time points. To determine the fold changes in phosphorylations, the band intensities of the images were determined using ImageJ, and the numerical values of phospho bands were divided into that of nonphospho
bands.
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Figure 4. The mutant TNFR1 (TNFR1-SH3-P/A) augments TNFα-mediated induction of NF-kB, but does not affect caspase-8 activation. TNFR1-SH3-P/A mutant
differentially affects TNFα-induced NF-kB activation. (A) To determine the NF-kB
activity, 293T cells were transfected with 150 ng of NF-kB luciferase reporter plasmid along with 150 ng of PC-3, TNFR1, or TNFR1-SH3-P/A for 48 h, then cells
were treated with 10 ng/mL TNFα for 6 h and luciferase activity was determined
using Luminometer (Thermo Fisher Scientific). TNFR1-SH3-P/A mutant differentially affects TNFα-induced caspase-8 activation. (B) To determine the impact of
mutant TNFR1 on caspase 8 activation, 293T cells were transfected with 150 ng of
PC-3, TNFR1, or TNFR1-SH3-P/A for 48 h, then cells were treated with 10 ng/mL
TNFα for 24 h and caspase-8 activation was measured by colorimetric caspase-8
activation assay kit.

al., 2008; Bertrand et al., 2008; Haas et al., 2009; Tokunaga
et al., 2009; Gerlach et al., 2011). In complex-1, TAK1 is
activated by autophosphorylation and activated TAK1
phosphorylates and activates MKK3/6, MKK4/7, and
IKKs. Activated IKKs induce NF-kB activation whereas
MKK3/6 and MKK4/7 phosphorylate and activate p38s
and JNKs, respectively. Overall, the ultimate target
activated in complex-1 is TAK1, and TAK1 activation can
explain how TNFα induces activations of NF-kB, JNK1/2,
and p38 (Wang et al., 2001).
Even though TNFR1 does not bear the PI3Kp85binding site, YXXM motif, we have previously shown
that PI3Kp85 binds to TNFR1 and induces synthesis
of phosphatidylinositol three phosphates (PIP3) by
activating PI3K (phosphoinositide 3-kinase) pathway,
which ultimately induces phosphorylation of AKT kinase
(Ozes et al., 1999; Ozes et al., 2001; Pincheira et al., 2008).
Since we cannot explain TNFα-mediated phosphorylation
of AKT by the formation of complex-1, we decided to look
at different domains of TNFR1 and found that TNFR1
has SH3-recognition sequence, PPAP, at the C-terminus
of TNFR1, Figure 1A. This prompted us to think that
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mechanism of activation of PI3K may rely on PPAP motif
and adaptor proteins bearing SH3 domain such as Grb2
can bind to this domain. Indeed, binding of Grb2 to TNFR1
has been shown before (Hildt and Oess, 1999), however,
they did not perform any mechanistic studies. Having this
in mind, we mutated PPAP sequence to APAA sequence
by site-directed mutagenesis and showed the expression
of mutant TNFR1 in 293T cells (Figures 1B and 1C). As
we anticipated, the ectopic expression of mutant TNFR1
not only inhibited TNFα-mediated phosphorylations of
ERK1/2, but also it completely inhibited TNFα-mediated
phosphorylation of AKT kinase (Figures 2A and 2B).
Downward’s team showed that the Ras-GTP complex
not only binds to RAF (Proto-oncogene serine/threonineprotein kinase) but also binds to catalytic subunit p110α
of PI3K. This binding activates PI3K complex which
produces PIP3 from PIP2, and resulting PIP3 binds to
PDK1 (phosphatidylinositol-activated kinase), activate
this kinase and activated PDK1 phosphorylate and
activate AKT. These breakthrough findings explained
GRB2-RAS-RAF-MEK-ERK and GRB2-RAS-PI3KPDK1-AKT pathways (Rodriguez-Viciana et al., 1994).

ÇOPUROĞLU et al. / Turk J Biol
This breakthrough findings of Downward’s team explained
as to how GRB2-RAS-RAF-MEK-ERK as well as GRB2RAS-PI3K-PDK1-AKT pathways. When we look at our
results in Figures 2A and 2B, this is exactly what we see
on TNFR1. The presence of Grb2-binding site is initiating
the formation of both GRB2-RAS-RAF-MEK-ERK as well
as GRB2-RAS-PI3K-PDK1-AKT complexes and mutation
of PPAP to APAA significantly affect phosphorylation
of ERKs and ablated TNFα-induced phosphorylation
of AKT. Recently, we have shown that TNFR1 bears two
tyrosine phosphorylation sites (Y360, Y401) and these
sites are phosphorylated upon TNFα stimulation and these
sites can initiate Grb2-Ras-RAF-ERK pathway. However,
according to our results Grb2-RAS-p110α-complex seems
to form primarily at PPAP site and initiates signaling
pathways which result in activation of ERKs and AKT.
As
mentioned
above,
TNFR1-induced
phosphorylations of p38 and JNK kinases are mediated
by activation of TAK1 in the complex-1. However, it was
recently shown that ASK1 can be recruited to TNFR1 by
A20 in a complex-1-independent manner and ASK1 can
phosphorylate JNK1/2 (Won et al., 2020). Also, Patel et
al. have shown that ASK1 can phosphorylate p38 kinases
(Patel et al., 2019). Since changing PPAP site to APAA
dramatically affected TNFα-induced phosphorylation
of p38/JNKs, it is possible that the structure of mutant
TNFR1 cannot accommodate the binding of ASK1 to
TNFR1 resulting in diminishment of TNFR1-induced
phosphorylations of JNKs and p38 kinases.

Since Grb2 has both SH3 and SH2 domains
(phosphotyrosine recognition domain), based on our
results, we postulate that after binding to PPAP via SH3
domain its SH2 domain can interact with phosphorylated
Y360/Y401. In fact, this is the most likely scenario of
TNFR1 signaling. Since GRB2 constitutively binds to
TNFR1 (Hapil et al., 2020), it can always initiate the
activation of RAS-controlled RAF and p100a pathways.
By doing so, the association of GRB2 with TNFR1 causes
persistent generation of signals from TNFR1, and addition
of TNFα can only further increase the activation of RASRAF and RAS-p110α pathways by simply increasing the
GRB2 load on TNFR1. Indeed, unlike other cytokines and
growth factors-mediated activation of ERK and AKT we
studied, the level of TNFα-induced activations of ERK and
AKT are always modest. The mode of action of GRB2 on
TNFR1 signaling is illustrated in Figure 5. In conclusion,
PPAP sequence of TNFR1 seems to have significant role in
initiating signaling events resulting in activations of ERK,
AKT, JNKs and p38 kinases by TNFα.
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Figure 5. The adaptor protein GRB2 is essential for TNFR1 signaling. The GRB2 constitutively bind to PPAP sequence of TNFR1 via its
SH3 domain. After TNFα binding to TNFR1, cSRC and JAK2 (which constitutively bind to TNFR1) phosphorylate Y360 and Y401. The
phosphorylated tyrosines were represented as single (P) on TNFR1. GRB2 binds to these tyrosine phosphorylated amino acids via its
SH2 domain. TNFR1-bound GRB2 binds to RAS and initiate RAS-induced RAS-RAF-ERK and RAS-p110α -AKT pathways.
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